Genscript Biotech Corp
HKEX:1548
Genscript Biotech Corp
HKEX:1548
Price:
13.75
HKD
3.31%
Market Closed
Market Cap:
HK$30.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Genscript Biotech Corp
HKEX:1548
|
CN |
Income Statement
Earnings Waterfall
Genscript Biotech Corp
Genscript Biotech Corp
Income Statement
Genscript Biotech Corp
Genscript Biotech Corp
Currency: USD
| Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
2
|
3
|
12
|
11
|
2
|
1
|
3
|
5
|
0
|
|
| Revenue |
87
N/A
|
99
+14%
|
115
+16%
|
125
+9%
|
153
+22%
|
201
+32%
|
231
+15%
|
241
+4%
|
273
+14%
|
318
+16%
|
391
+23%
|
454
+16%
|
490
+8%
|
570
+16%
|
626
+10%
|
712
+14%
|
560
-21%
|
454
-19%
|
594
+31%
|
552
-7%
|
960
+74%
|
|
| Gross Profit | ||||||||||||||||||||||
| Cost of Revenue |
(30)
|
(33)
|
(39)
|
(42)
|
(48)
|
(58)
|
(72)
|
(85)
|
(93)
|
(108)
|
(135)
|
(168)
|
(208)
|
(258)
|
(322)
|
(409)
|
(290)
|
(225)
|
(322)
|
(266)
|
(406)
|
|
| Gross Profit |
57
N/A
|
66
+16%
|
76
+15%
|
83
+9%
|
105
+26%
|
143
+37%
|
159
+11%
|
156
-2%
|
180
+16%
|
210
+16%
|
256
+22%
|
286
+12%
|
283
-1%
|
312
+11%
|
304
-3%
|
304
0%
|
271
-11%
|
229
-15%
|
272
+19%
|
286
+5%
|
553
+94%
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(37)
|
(40)
|
(50)
|
(53)
|
(67)
|
(107)
|
(150)
|
(206)
|
(304)
|
(371)
|
(462)
|
(567)
|
(805)
|
(912)
|
(736)
|
(761)
|
(110)
|
89
|
(381)
|
51
|
(294)
|
|
| Selling, General & Administrative |
(46)
|
(48)
|
(51)
|
(54)
|
(65)
|
(78)
|
(78)
|
(98)
|
(126)
|
(145)
|
(198)
|
(236)
|
(304)
|
(356)
|
(352)
|
(374)
|
(192)
|
(101)
|
(209)
|
(98)
|
(227)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
(28)
|
(74)
|
(109)
|
(186)
|
(239)
|
(263)
|
(323)
|
(358)
|
(361)
|
(390)
|
(420)
|
(53)
|
(250)
|
(54)
|
151
|
(71)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
9
|
8
|
1
|
1
|
(2)
|
(0)
|
4
|
3
|
8
|
13
|
(1)
|
(8)
|
(142)
|
(195)
|
6
|
34
|
135
|
441
|
(118)
|
(2)
|
3
|
|
| Operating Income |
20
N/A
|
26
+34%
|
26
+0%
|
30
+13%
|
38
+26%
|
36
-4%
|
9
-76%
|
(50)
N/A
|
(124)
-146%
|
(161)
-30%
|
(206)
-28%
|
(281)
-36%
|
(522)
-86%
|
(600)
-15%
|
(432)
+28%
|
(457)
-6%
|
161
N/A
|
318
+98%
|
(109)
N/A
|
337
N/A
|
259
-23%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
3
|
5
|
6
|
5
|
1
|
4
|
15
|
17
|
12
|
8
|
8
|
7
|
5
|
3
|
1
|
4
|
23
|
21
|
(12)
|
(286)
|
(326)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
(2)
|
(82)
|
(80)
|
0
|
0
|
0
|
0
|
0
|
(12)
|
(49)
|
(46)
|
(8)
|
(398)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(1)
|
(1)
|
(3)
|
(5)
|
(5)
|
(8)
|
(6)
|
|
| Pre-Tax Income |
23
N/A
|
31
+36%
|
33
+4%
|
34
+6%
|
39
+12%
|
40
+4%
|
23
-43%
|
(34)
N/A
|
(114)
-239%
|
(235)
-107%
|
(282)
-20%
|
(274)
+3%
|
(517)
-89%
|
(597)
-15%
|
(432)
+28%
|
(454)
-5%
|
169
N/A
|
286
+69%
|
(171)
N/A
|
35
N/A
|
(471)
N/A
|
|
| Net Income | ||||||||||||||||||||||
| Tax Provision |
(5)
|
(6)
|
(6)
|
(6)
|
(12)
|
(10)
|
(2)
|
3
|
(4)
|
(10)
|
0
|
(3)
|
(1)
|
1
|
4
|
6
|
(6)
|
(15)
|
(3)
|
(17)
|
(62)
|
|
| Income from Continuing Operations |
18
|
25
|
27
|
28
|
27
|
30
|
21
|
(30)
|
(118)
|
(245)
|
(281)
|
(277)
|
(518)
|
(596)
|
(428)
|
(448)
|
163
|
271
|
(174)
|
17
|
(532)
|
|
| Income to Minority Interest |
0
|
0
|
(0)
|
(1)
|
(1)
|
(3)
|
0
|
9
|
21
|
62
|
76
|
94
|
160
|
193
|
201
|
259
|
260
|
148
|
107
|
65
|
(0)
|
|
| Net Income (Common) |
18
N/A
|
25
+43%
|
26
+5%
|
28
+7%
|
26
-7%
|
27
+2%
|
21
-20%
|
(22)
N/A
|
(97)
-348%
|
(183)
-88%
|
(205)
-12%
|
(183)
+11%
|
(359)
-96%
|
(403)
-12%
|
(227)
+44%
|
(189)
+17%
|
(95)
+50%
|
(177)
-85%
|
2 962
N/A
|
3 112
+5%
|
(533)
N/A
|
|
| EPS (Diluted) |
0.01
N/A
|
0.02
+100%
|
0.02
N/A
|
0.02
N/A
|
0.02
N/A
|
0.02
N/A
|
0.01
-50%
|
-0.01
N/A
|
-0.05
-400%
|
-0.1
-100%
|
-0.11
-10%
|
-0.09
+18%
|
-0.18
-100%
|
-0.19
-6%
|
-0.11
+42%
|
-0.09
+18%
|
-0.04
+56%
|
-0.08
-100%
|
1.39
N/A
|
1.44
+4%
|
-0.25
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
